Swiss National Bank’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-160,600
| Closed | -$546K | – | 2561 |
|
|
2018
Q3 | $546K | Hold |
160,600
| – | – | ﹤0.01% | 2386 |
|
|
2018
Q2 | $604K | Hold |
160,600
| – | – | ﹤0.01% | 2398 |
|
|
2018
Q1 | $657K | Buy |
160,600
+18,500
| +13% | +$86.1K | ﹤0.01% | 2298 |
|
|
2017
Q4 | $661K | Buy |
142,100
+11,600
| +9% | +$63.9K | ﹤0.01% | 2320 |
|
|
2017
Q3 | $927K | Hold |
130,500
| – | – | ﹤0.01% | 2105 |
|
|
2017
Q2 | $944K | Hold |
130,500
| – | – | ﹤0.01% | 2092 |
|
|
2017
Q1 | $804K | Hold |
130,500
| – | – | ﹤0.01% | 2156 |
|
|
2016
Q4 | $765K | Sell |
130,500
-14,900
| -10% | -$81.4K | ﹤0.01% | 2197 |
|
|
2016
Q3 | $772K | Hold |
145,400
| – | – | ﹤0.01% | 2137 |
|
|
2016
Q2 | $963K | Sell |
145,400
-30,700
| -17% | -$172K | ﹤0.01% | 1990 |
|
|
2016
Q1 | $795K | Buy |
176,100
+31,900
| +22% | +$127K | ﹤0.01% | 2044 |
|
|
2015
Q4 | $728K | Hold |
144,200
| – | – | ﹤0.01% | 2044 |
|
|
2015
Q3 | $508K | Buy |
144,200
+17,300
| +14% | +$116K | ﹤0.01% | 2174 |
|
|
2015
Q2 | $1.27M | Buy |
126,900
+16,500
| +15% | +$177K | ﹤0.01% | 1630 |
|
|
2015
Q1 | $1.41M | Buy |
110,400
+11,200
| +11% | +$144K | ﹤0.01% | 1537 |
|
|
2014
Q4 | $1.4M | Buy |
99,200
+2,200
| +2% | +$34.1K | 0.01% | 1520 |
|
|
2014
Q3 | $1.33M | Hold |
97,000
| – | – | 0.01% | 1483 |
|
|
2014
Q2 | $1.49M | Hold |
97,000
| – | – | 0.01% | 1457 |
|
|
2014
Q1 | $1.65M | Buy |
97,000
+27,100
| +39% | +$409K | 0.01% | 1336 |
|
|
2013
Q4 | $905K | Hold |
69,900
| – | – | ﹤0.01% | 1587 |
|
|
2013
Q3 | $706K | Sell |
69,900
-3,900
| -5% | -$34.7K | ﹤0.01% | 1695 |
|
|
2013
Q2 | $551K | Buy |
+73,800
| New | +$577K | ﹤0.01% | 1845 |
|
Swiss National Bank's KERX Position: Q4 2018 in Review
Swiss National Bank sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 160,600 shares — an estimated $546K sold.
Swiss National Bank first reported a position in KERX in Q2 2013 and held it in 22 quarters. The position peaked at $1.65M in Q1 2014. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.
- Swiss National Bank reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
- Swiss National Bank sold 160,600 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $546K.
- Swiss National Bank first reported a position in Keryx Biopharmaceuticals Inc in Q2 2013 and held it in 22 quarters.
- Swiss National Bank's Keryx Biopharmaceuticals Inc position peaked at $1.65M in Q1 2014.
- 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.
Based on Swiss National Bank's 13F filing for Q4 2018, filed 13 Feb 2019.